Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FFWLX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,389
Award facts
- Contract value 100% obligated
- $1,388.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,388.62 by the Defense Logistics Agency on September 11, 2025, for the supply of Nexplanon 68 mg implants. The delivery order, which carries no set-aside designation, is scheduled for completion by October 2, 2025, with performance at the company's Park Ridge facility. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare systems worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company maintains a robust portfolio of pharmaceutical product deliveries to military and federal healthcare facilities, including prescription medications, biologics, vaccines, and specialty pharmaceutical items. The DLA, as a component of the Department of Defense, utilizes vehicles such as the SPE2DB program to ensure consistent access to essential medications and medical supplies across military health facilities on a national and international basis, with DMS Pharmaceutical Group serving as a primary distribution partner for these critical healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FFWLX?
SPE2DB25FFWLX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FFWLX worth?
The government has obligated $1,389 on SPE2DB25FFWLX.
Is contract SPE2DB25FFWLX an order under another contract?
Yes. SPE2DB25FFWLX is a delivery order under SPE2DB24D9315, an indefinite delivery contract.
Was contract SPE2DB25FFWLX competed?
The extent of competition for SPE2DB25FFWLX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award